Microtome Market By Product (Microtome Devices, Accessories) , By Technology (Fully Automated, Semi-Automated, Manual) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Microtome Market Expected to Garner $263.3 Million by 2033, Growing at a CAGR of 6.2%
Abstract: The global microtome market is expected to grow primarily due to the growing need for precise sectioning in various microscopy applications. The North America region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global microtome market was valued at $144.5 million in 2023 and is expected to register a revenue of $263.3 million by 2033 at a CAGR of 6.2% during the forecast period 2024-2033.
Dynamics of the Market
The increasing need for precise sectioning in various microscopy applications, versatility in microscopy techniques, and the growth in biotechnology & pharmaceutical sectors are expected to make the microtome market a highly profitable one in the forecast period. Besides, the rising need for accurate tissue sections in pathology diagnosis is another factor predicted to boost the market growth.
However, according to market analysts, risk of accidents & injuries and the high repair costs for rotating microscopes might restrain the growth of the market.
Advancements in automation and the integration of microtomes with advanced imaging technologies to improve diagnostic capabilities are predicted to offer numerous growth opportunities for the market in the forecast period. Moreover, innovations enabling high-throughput sectioning and compatibility with specialized techniques is expected to propel the microtome market forward in the coming years.
Key Players of the Market
The major players of the microtome market include Diapath S.P.A., Leica Biosystems Nussloch GmbH, Sakura Finetek Europe B.V., AGD Biomedicals, MEDITE GmbH, Thermo Fisher Scientific, Boeckeler Instruments, Scientific Instruments Pvt. Ltd., Alltion, S.M., and Nanolytik.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Additional benefits you will get with this purchase are:
By Product
Abstract: The global microtome market is expected to grow primarily due to the growing need for precise sectioning in various microscopy applications. The North America region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global microtome market was valued at $144.5 million in 2023 and is expected to register a revenue of $263.3 million by 2033 at a CAGR of 6.2% during the forecast period 2024-2033.
Dynamics of the Market
The increasing need for precise sectioning in various microscopy applications, versatility in microscopy techniques, and the growth in biotechnology & pharmaceutical sectors are expected to make the microtome market a highly profitable one in the forecast period. Besides, the rising need for accurate tissue sections in pathology diagnosis is another factor predicted to boost the market growth.
However, according to market analysts, risk of accidents & injuries and the high repair costs for rotating microscopes might restrain the growth of the market.
Advancements in automation and the integration of microtomes with advanced imaging technologies to improve diagnostic capabilities are predicted to offer numerous growth opportunities for the market in the forecast period. Moreover, innovations enabling high-throughput sectioning and compatibility with specialized techniques is expected to propel the microtome market forward in the coming years.
Key Players of the Market
The major players of the microtome market include Diapath S.P.A., Leica Biosystems Nussloch GmbH, Sakura Finetek Europe B.V., AGD Biomedicals, MEDITE GmbH, Thermo Fisher Scientific, Boeckeler Instruments, Scientific Instruments Pvt. Ltd., Alltion, S.M., and Nanolytik.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Consumer Buying Behavior Analysis
- Investment Opportunities
- Upcoming/New Entrant by Regions
- Technology Trend Analysis
- Go To Market Strategy
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Pain Point Analysis
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
- SWOT Analysis
By Product
- Microtome Devices
- Accessories
- Fully Automated
- Semi-Automated
- Manual
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
- Key Market Players
- Diapath S.P.A.
- Sakura Finetek Europe B.V.
- Leica Biosystems Nussloch GmbH
- AGD Biomedicals
- Thermo Fisher Scientific Inc.
- MEDITE GmbH
- Boeckeler Instruments
- Alltion, S.M.
- Scientific Instruments Pvt. Ltd.
- Nanolytik
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: MICROTOME MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Microtome Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Accessories
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: MICROTOME MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Fully Automated
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Semi-Automated
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Manual
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: MICROTOME MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By Technology
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Microtome Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By Technology
6.2.6. Canada Microtome Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By Technology
6.2.7. Mexico Microtome Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By Technology
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By Technology
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Microtome Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By Technology
6.3.6. UK Microtome Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By Technology
6.3.7. France Microtome Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By Technology
6.3.8. Spain Microtome Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By Technology
6.3.9. Italy Microtome Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By Technology
6.3.10. Rest Of Europe Microtome Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By Technology
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By Technology
6.4.4. Market Size and Forecast, By Country
6.4.5. China Microtome Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By Technology
6.4.6. Japan Microtome Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By Technology
6.4.7. India Microtome Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By Technology
6.4.8. South Korea Microtome Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By Technology
6.4.9. Australia Microtome Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By Technology
6.4.10. Rest of Asia-Pacific Microtome Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By Technology
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By Technology
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Microtome Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By Technology
6.5.6. Saudi Arabia Microtome Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By Technology
6.5.7. UAE Microtome Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By Technology
6.5.8. South Africa Microtome Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By Technology
6.5.9. Rest of LAMEA Microtome Market
6.5.9.1. Market Size and Forecast, By Product
6.5.9.2. Market Size and Forecast, By Technology
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Diapath S.P.A.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Sakura Finetek Europe B.V.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Leica Biosystems Nussloch GmbH
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. AGD Biomedicals
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Thermo Fisher Scientific Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. MEDITE GmbH
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Boeckeler Instruments
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Alltion, S.M.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Scientific Instruments Pvt. Ltd.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Nanolytik
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: MICROTOME MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Microtome Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Accessories
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: MICROTOME MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Fully Automated
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Semi-Automated
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Manual
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: MICROTOME MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By Technology
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Microtome Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By Technology
6.2.6. Canada Microtome Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By Technology
6.2.7. Mexico Microtome Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By Technology
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By Technology
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Microtome Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By Technology
6.3.6. UK Microtome Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By Technology
6.3.7. France Microtome Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By Technology
6.3.8. Spain Microtome Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By Technology
6.3.9. Italy Microtome Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By Technology
6.3.10. Rest Of Europe Microtome Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By Technology
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By Technology
6.4.4. Market Size and Forecast, By Country
6.4.5. China Microtome Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By Technology
6.4.6. Japan Microtome Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By Technology
6.4.7. India Microtome Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By Technology
6.4.8. South Korea Microtome Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By Technology
6.4.9. Australia Microtome Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By Technology
6.4.10. Rest of Asia-Pacific Microtome Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By Technology
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By Technology
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Microtome Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By Technology
6.5.6. Saudi Arabia Microtome Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By Technology
6.5.7. UAE Microtome Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By Technology
6.5.8. South Africa Microtome Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By Technology
6.5.9. Rest of LAMEA Microtome Market
6.5.9.1. Market Size and Forecast, By Product
6.5.9.2. Market Size and Forecast, By Technology
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Diapath S.P.A.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Sakura Finetek Europe B.V.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Leica Biosystems Nussloch GmbH
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. AGD Biomedicals
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Thermo Fisher Scientific Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. MEDITE GmbH
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Boeckeler Instruments
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Alltion, S.M.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Scientific Instruments Pvt. Ltd.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Nanolytik
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
